Nearly one-third of chronic hepatitis C patients
with liver cirrhosis and 12% with advanced fibrosis progressed to
decompensation within five years, and 23% and 11%, respectively, died,
according to a study presented at the
American Association for the Study of Liver
Diseases (AASLD) Liver Meeting last month in Boston. These findings underscore the
urgent need for